Eleven Biotherapeutics To Present At Oppenheimer 25th Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Abbie Celniker, Ph.D., President and Chief Executive Officer, will present a company overview at the Oppenheimer 25th Annual Healthcare Conference in New York on Thursday, December 11, 2014 at 10:55 a.m. ET.

Help employers find you! Check out all the jobs and post your resume.